FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996394494> ?p ?o ?g. }

• W2996394494 endingPage "PR02" @default.
• W2996394494 startingPage "PR02" @default.
• W2996394494 abstract "Abstract Background: mRNA datasets have defined two molecular subtypes of pancreatic ductal adenocarcinoma (PDAC), classical and squamous, with distinct clinical characteristics and raising the possibility of subtype specific therapies (Collisson et al., 2019). The aggressive squamous subtype is characterized by poorer patient survival and loss of endodermal differentiation markers GATA6 and PDX1, but neither PDAC subtypes nor metastasis can be explained by genetic mutations alone (Reiter et al., 2018). Conversely, widespread epigenetic reprogramming is associated with progression to more aggressive phenotypes (McDonald et al., 2017), suggesting that aggressive molecular subtype is likely to be epigenetically driven. The role of DNA 5’methylcytosine (5’mc) in PDAC has been previously unclear due to an inability to distinguish this mark from the reciprocal activation mark DNA 5’hydroxymethylcytosine (5’hmC), mediated by Ten-eleven-translocation (TET) enzymes. Moreover, 5’hmc is dynamically regulated during pancreatic differentiation, but a role during PDAC initiation or progression has not been previously addressed. Methods: PDAC patients who underwent surgical resection at the Churchill Hospital, Oxford (n=146) had FFPE tumor tissue mutation comprehensively profiled by illumina hotspot array (300X), mRNA microarray, and the first epigenetic separation of 5’mc and 5’hmc on FFPE via oxidative bisulphite sequencing (oxBS) and illumina EPIC arrays. iCluster was used to highlight epigenetic PDAC subtypes and compare to existing TCGA datasets. Orthotopic models were employed to test whether the Squamous subtype is defined by 5’hmc loss and if this can be converted to the classical subtype in vivo. Results: Compared to healthy tissue, PDAC tumors demonstrate loss of 5’hmC at genes critical for pancreatic development and associated with PDAC progression, including MAPK signaling and TP53 targets. 5’hmC was preferentially lost in aggressive molecular subtypes (squamous) compared to the classical subtypes and was associated with SMAD4 mutations and reduced TET2. Overexpression of TET2 in squamous tumor cells restored 5’hmc and the expression of classical associated genes (e.g., GATA6 and PDX1), suggesting that 5’hmC is a master epigenetic regulator of PDAC molecular subtypes. Notably, we find TET2 stability is regulated by glucose levels, implying the widespread hypoglycemia seen in PDAC patients may contribute to progression of aggressive subtypes through loss of 5’hmC. Concomitantly, as metformin and vitamin C independently enhance endogenous TET2 activity, we find that this combination acts synergistically on squamous tumors to increase 5’hmC and expression of a classical-subtype phenotype, suggesting subtype switching is achievable in vitro and in vivo. Conclusion: These results identify 5’hmC as a regulator of molecular subtype that can be targeted in vivo using well-tolerated drugs. This abstract is also being presented as Poster A39. Citation Format: Michael Eyres, Simone Lanfredini, Frances Willenbrock, Asmita Thapa, Andrew Blake, Adam Burns, Ahmad Sabbagh, Aswin Abraham, Timothy Maughan, Zahir Soonawalla, Anna Schuh, Somnath Mukhergee, Eric O'Neill. Loss of TET2 activity results in epigenetic instability and drives PDAC molecular subtypes [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care; 2019 Sept 6-9; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2019;79(24 Suppl):Abstract nr PR02." @default.
• W2996394494 created "2019-12-26" @default.
• W2996394494 creator A5020152756 @default.
• W2996394494 creator A5026585062 @default.
• W2996394494 creator A5035577348 @default.
• W2996394494 creator A5036760579 @default.
• W2996394494 creator A5038023467 @default.
• W2996394494 creator A5047754738 @default.
• W2996394494 creator A5048378829 @default.
• W2996394494 creator A5048742778 @default.
• W2996394494 creator A5064655386 @default.
• W2996394494 creator A5065967242 @default.
• W2996394494 creator A5074839524 @default.
• W2996394494 creator A5086219801 @default.
• W2996394494 creator A5089829733 @default.
• W2996394494 date "2019-12-13" @default.
• W2996394494 modified "2023-10-16" @default.
• W2996394494 title "Abstract PR02: Loss of TET2 activity results in epigenetic instability and drives PDAC molecular subtypes" @default.
• W2996394494 doi "https://doi.org/10.1158/1538-7445.panca19-pr02" @default.
• W2996394494 hasPublicationYear "2019" @default.
• W2996394494 type Work @default.
• W2996394494 sameAs 2996394494 @default.
• W2996394494 citedByCount "1" @default.
• W2996394494 countsByYear W29963944942021 @default.
• W2996394494 crossrefType "journal-article" @default.
• W2996394494 hasAuthorship W2996394494A5020152756 @default.
• W2996394494 hasAuthorship W2996394494A5026585062 @default.
• W2996394494 hasAuthorship W2996394494A5035577348 @default.
• W2996394494 hasAuthorship W2996394494A5036760579 @default.
• W2996394494 hasAuthorship W2996394494A5038023467 @default.
• W2996394494 hasAuthorship W2996394494A5047754738 @default.
• W2996394494 hasAuthorship W2996394494A5048378829 @default.
• W2996394494 hasAuthorship W2996394494A5048742778 @default.
• W2996394494 hasAuthorship W2996394494A5064655386 @default.
• W2996394494 hasAuthorship W2996394494A5065967242 @default.
• W2996394494 hasAuthorship W2996394494A5074839524 @default.
• W2996394494 hasAuthorship W2996394494A5086219801 @default.
• W2996394494 hasAuthorship W2996394494A5089829733 @default.
• W2996394494 hasConcept C104317684 @default.
• W2996394494 hasConcept C121608353 @default.
• W2996394494 hasConcept C125449221 @default.
• W2996394494 hasConcept C127716648 @default.
• W2996394494 hasConcept C150194340 @default.
• W2996394494 hasConcept C190727270 @default.
• W2996394494 hasConcept C2779050171 @default.
• W2996394494 hasConcept C2780265364 @default.
• W2996394494 hasConcept C41091548 @default.
• W2996394494 hasConcept C502942594 @default.
• W2996394494 hasConcept C54355233 @default.
• W2996394494 hasConcept C86339819 @default.
• W2996394494 hasConcept C86803240 @default.
• W2996394494 hasConceptScore W2996394494C104317684 @default.
• W2996394494 hasConceptScore W2996394494C121608353 @default.
• W2996394494 hasConceptScore W2996394494C125449221 @default.
• W2996394494 hasConceptScore W2996394494C127716648 @default.
• W2996394494 hasConceptScore W2996394494C150194340 @default.
• W2996394494 hasConceptScore W2996394494C190727270 @default.
• W2996394494 hasConceptScore W2996394494C2779050171 @default.
• W2996394494 hasConceptScore W2996394494C2780265364 @default.
• W2996394494 hasConceptScore W2996394494C41091548 @default.
• W2996394494 hasConceptScore W2996394494C502942594 @default.
• W2996394494 hasConceptScore W2996394494C54355233 @default.
• W2996394494 hasConceptScore W2996394494C86339819 @default.
• W2996394494 hasConceptScore W2996394494C86803240 @default.
• W2996394494 hasIssue "24_Supplement" @default.
• W2996394494 hasLocation W29963944941 @default.
• W2996394494 hasOpenAccess W2996394494 @default.
• W2996394494 hasPrimaryLocation W29963944941 @default.
• W2996394494 hasRelatedWork W2002128513 @default.
• W2996394494 hasRelatedWork W2002638838 @default.
• W2996394494 hasRelatedWork W2044401234 @default.
• W2996394494 hasRelatedWork W2063202829 @default.
• W2996394494 hasRelatedWork W2096534598 @default.
• W2996394494 hasRelatedWork W2141887265 @default.
• W2996394494 hasRelatedWork W2884161662 @default.
• W2996394494 hasRelatedWork W2996394494 @default.
• W2996394494 hasRelatedWork W3017308777 @default.
• W2996394494 hasRelatedWork W4310701073 @default.
• W2996394494 hasVolume "79" @default.
• W2996394494 isParatext "false" @default.
• W2996394494 isRetracted "false" @default.
• W2996394494 magId "2996394494" @default.
• W2996394494 workType "article" @default.